Preferential recognition of epitopes on AGE-IgG by the autoantibodies in rheumatoid arthritis patients

Human Immunology

Volumn 74, Issue 1, 2013, Pages 23-27

  Ahmad, Saman ^a   Habib, Safia ^a   Moinuddin, ^a   Ali, Asif ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AUTOANTIBODY; CARBONYL DERIVATIVE; EPITOPE; GLUCOSE; IMMUNOGLOBULIN G;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; COMMERCIAL PHENOMENA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOLECULAR RECOGNITION; NITROBLUE TETRAZOLIUM TEST; ONSET AGE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RHEUMATOID ARTHRITIS;

ADULT; AGE FACTORS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BINDING, COMPETITIVE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; GLYCOCONJUGATES; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NITROBLUE TETRAZOLIUM; OXIDATION-REDUCTION; PROTEIN BINDING; PROTEIN CARBONYLATION;

EID: 84870860517     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.10.008     Document Type: Article

References (29)

1. Edmonds S.E., Ellis G., Gaffney K., Archer J., Blake D.R. Hypoxia and the rheumatoid joint: immunological and therapeutic implications. Scand J Rheumatol 1995, 24:163-168.
2. Hagfors L., Leanderson P., Skoldstam L., Andersson J., Johansson G. Antioxidant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, Mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutr J 2003, 2:5.
3. Shacter E. Protein oxidative damage. Methods Enzymol 2000, 319:428-436.
4. Maillard L.C. Action des acides amines sur les sucres: formation des melanoidines par voie methodique. CR Acad Sci (Paris) 1912, 154:66-68.
5. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405-412.
6. Takahashi M., Suzuki M., Kushida K., Miyamoto S., Inoue T. Relationship between pentosidine levels in serum and urine activity in rheumatoid arthritis. Br J Rheumatol 1997, 36:637-642.
7. Rasheed Z., Kumar L., Abbas S., Prasad I., Ansari N.A., Ahmad R. Advanced glycation end-products damaged IgG, a target for circulating autoantibodies in patients with type I diabetes mellitus. Open Glycosci 2009, 2:1-8.
8. Austin G.E., Mullins R.H., Morin L.G. Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients. Clin Chem 1987, 33:2220-2224.
9. Rasheed Z. Hydroxyl radical damaged Immunoglobulin G in patients with rheumatoid arthritis: biochemical and immunological studies. Clin Biochem 2008, 41:663-669.
10. Arnett F.C., Edworthy S.M., Block D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arth Rheum 1988, 31:315-324.
11. Ali R., Alam K. Evaluation of antibodies against oxygen free radical-modified DNA by ELISA. Methods Mol Biol 2002, 186:171-181.
12. Levine R.L., Williams J., Stadtman E.R., Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994, 233:346-357.
13. Dixit K., Khan M.A., Sharma Y.D., Moinuddin, Alam K. Peroxynitrite-induced modification of H2A histone presents epitopes which are strongly bound by human anti-DNA autoantibodies: Role of peroxynitrite-modified-H2A in SLE induction and progression. Human Immunol 2011, 72:219-225.
14. Johnson R., Metcalf P.A., Baker J.R. Fructosamine: a new approach to the estimation of serum glycosylation. An index of diabetic control. Clin Chim Acta 1982, 127:87-95.
15. Habib S. Moinuddin, Ali R. Acquired antigenicity of DNA after modification with peroxynitrite. Int J Biol Macromol 2005, 31:221-225.
16. Ansari N.A., Moinuddin, Alam K., Ali A. Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: role of protein glycation in the disease process. Human Immunol 2009, 70:417-424.
17. Tai A.W.H., Newkirk M.M. An autoantibody targeting glycated IgG is associated with elevated serum immune complexes in rheumatoid arthritis (RA). Clin Exp Immunol 2000, 120:188-193.
18. Newkirk M.M., Goldbach-Mansky R., Lee J., Hoxworth J., McCoy A., Yarboro C., et al. Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-IgE in patients with early synovitis. Arthritis Res Ther 2003, 5:R82-R90.
19. Ahmad S., Moinuddin, Khan R.H., Ali A. Physicochemical studies on glycation induced structural changes in human IgG. IUBMB Life 2012, 64:151-156.
20. Ahmad S., Moinuddin, Ali A. Immunological studies on glycated human IgG. Life Sci 2012, 90:980-987.
21. Khurana R., Berney S.K. Clinical aspects of rheumatoid arthritis. Pathphysiology 2005, 15:153-165.
22. Cuzzocrea S. Role of nitric oxide and reactive oxygen species in arthritis. Curr Pharm Des 2006, 12:3551-3770.
23. Ostrakhovitch E.A., Afanas'ev I.B. Oxidative stress in rheumatoid arthritis leukocytes: suppression by rutin and other ani-oxidants and chelators. Biochem Pharmacol 2001, 62:743-746.
24. Monnier M.V., Kohn R., Cerami A. Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci (USA) 1984, 81:583-587.
25. Singh R., Barden A., Mori T., Beilin L. Advanced glycation end-products: a review. Diabetologia 2001, 44:129-146.
26. Chen J.R., Takahashi S., Suzuki M., Kushida K., Miyamoto S., Inoue T. Pentosidine in synovial fliud in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis. J Rheumatol 1998, 25:2440-2444.
27. Furumitsu Y., Inaba M., Yukioka K., Yukoika M., Kumeda Y., Azuma Y., et al. Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis. J Rheumatol 2000, 27:64-70.
28. Miyata T., Ishiguro N., Yasuda Y., Ito T., Nangaku M., Iwata H., et al. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Biochem Biophys Res Comm 1998, 244:45-49.
29. Ligier S., Fortin P.R., Newkirk M.M. A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE. Br J Rheumatol 1998, 37:1307-1314.